Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Jan 5;13(1):e1001936.
doi: 10.1371/journal.pmed.1001936. eCollection 2016 Jan.

Data Sharing as Part of the Normal Scientific Process: A View from the Pharmaceutical Industry

Affiliations
Comment

Data Sharing as Part of the Normal Scientific Process: A View from the Pharmaceutical Industry

Patrick Vallance et al. PLoS Med. .

Abstract

Reflecting on the WHO consultation on developing global norms for sharing data and results during public health emergencies, Patrick Vallance and colleagues argue that there are significant benefits to the principle of data sharing.

PubMed Disclaimer

Conflict of interest statement

We have read the journal's policy and have the following conflicts: PV is a President at GlaxoSmithKline and holds stock or stock options in GlaxoSmithKline. AF is Head of Medical Policy at GlaxoSmithKline and holds stock or stock options in GlaxoSmithKline. MS is Chief Medical Officer at GlaxoSmithKline and holds stock or stock options in GlaxoSmithKline. PV is a member of the Editorial Board of PLOS Medicine.

Comment on

References

    1. Modjarrad K, Moorthy VS, Millet P, Gsell P-S, Roth C, Kieny M-P. Developing global norms for sharing data and results during public health emergencies. PLoS Med 2015; 13(1);e1001935 10.1371/journal.pmed.1001935 - DOI - PMC - PubMed
    1. The Royal Society. Science as an open enterprise. https://royalsociety.org/~/media/policy/projects/sape/2012-06-20-saoe.pdf
    1. Institute of Medicine. Sharing clinical trial data: maximizing benefit, minimizing risk. http://iom.nationalacademies.org/Reports/2015/Sharing-Clinical-Trial-Dat...
    1. Nisen P, Rockhold F. Access to patient-level data from GlaxoSmithKline clinical trials. N Engl J Med 2013; 369: 475–478. 10.1056/NEJMsr1302541 - DOI - PubMed
    1. Gamo F-J, Sanz LM, Vidal J, de Cozar C, Alvarez E, Lavandera J-L et al. (2010). Thousands of chemical starting points for antimalarial lead identification. Nature 2010; 465 (7296): 305–310. 10.1038/nature09107 - DOI - PubMed